Virion Therapeutics Reports Broad and Sustained Anti-HBV Immunity Following a Single VRON-0200 Dose in the Majority of Chronically HBV-Infected Patients From its Phase 1b Study at CROI 2026 Virion ...

PHILADELPHIA--(BUSINESS WIRE)--Virion Therapeutics, LLC, a clinical-stage biotechnology company developing novel T cell-based immunotherapies that utilize checkpoint modifiers, today announced at the ...

Marbache Lecture a proposé une aventure immersive animée par Cindy Millon Virion. Onze enfants ont répondu présent samedi après-midi pour ...

Detailed price information for Theralase Technologies Inc. (TLT-X) from The Globe and Mail including charting and trades.

Réunis pour le dernier conseil municipal de la mandature, les élus ont validé plusieurs décisions, notamment le compte ...

PHILADELPHIA, February 22, 2026--Virion Therapeutics, LLC, a clinical-stage biotechnology company developing novel T cell-based immunotherapies that utilize checkpoint modifiers, today announced at ...

Retrouvez les photos de l'aventure immersive avec Cindy Millon Virion organisée samedi 7 mars par Marbache Lecture à la MJC de Marbache ...

Detailed price information for Atea Pharmaceuticals Inc (AVIR-Q) from The Globe and Mail including charting and trades.

PHILADELPHIA, PA — Virion Therapeutics LLC reported data showing its experimental hepatitis B immunotherapy VRON-0200 generated sustained immune responses in chronically infected patients following a ...

PITTSBURGH, PA — Pennsylvania law enforcement and emergency agencies say extensive security and safety planning is underway ...

BACKGROUND: Aortic valve calcification increases leaflet stiffness and contributes to the development of calcific aortic valve disease. The molecular and cellular mechanisms underlying calcification ...